Organon & Co.
OGN
$13.31
-$0.02-0.15%
NYSE
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -3.12% | -5.93% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -3.12% | -5.93% | |||
| Cost of Revenue | -9.58% | 1.09% | |||
| Gross Profit | 3.13% | -11.85% | |||
| SG&A Expenses | -1.62% | 3.86% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -6.02% | 2.52% | |||
| Operating Income | 11.89% | -34.05% | |||
| Income Before Tax | 243.92% | -160.91% | |||
| Income Tax Expenses | 17.54% | -31.33% | |||
| Earnings from Continuing Operations | 171.22% | -228.13% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 171.22% | -228.13% | |||
| EBIT | 11.89% | -34.05% | |||
| EBITDA | 5.59% | -26.41% | |||
| EPS Basic | 171.16% | -228.03% | |||
| Normalized Basic EPS | 64.96% | -59.64% | |||
| EPS Diluted | 169.81% | -229.16% | |||
| Normalized Diluted EPS | 63.38% | -59.54% | |||
| Average Basic Shares Outstanding | 0.08% | 0.08% | |||
| Average Diluted Shares Outstanding | 1.05% | -0.18% | |||
| Dividend Per Share | 0.00% | 0.00% | |||
| Payout Ratio | 2.76% | -2.04% | |||